Research / RIVN / Fundamental state Inspectable configuration
State dimensions Filing 0001874178-22-000029 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
1291.58% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
440.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1088.42% · OPTIONAL · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
520.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
-528.42% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-1662.11% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
575.79% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
333.68% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/4 normalized Level 3 Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/8 normalized Level 3 Sep 30, 2022 0/9 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 4/9 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 2229.09%
Current 1291.58%
Delta -937.51% Capex Intensity Decreased
Previous 3261.82%
Current 440.00%
Delta -2821.82% Cash Generation Increased
Previous -4767.27%
Current -1088.42%
Delta 3678.85% Inventory Pressure Increased
Previous 498.18%
Current 520.00%
Delta 21.82% Margin Increased
Previous -845.45%
Current -528.42%
Delta 317.03% Profitability Increased
Previous -7672.73%
Current -1662.11%
Delta 6010.62% R And D Intensity Decreased
Previous 3363.64%
Current 575.79%
Delta -2787.85% Sbc Intensity Decreased
Previous 1036.36%
Current 333.68%
Delta -702.68% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.